.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
West Coast Cure is stocked at 297 licensed dispensaries across California and Maine, 295 of them in California, with the deepest coverage in Los Angeles, Santa Ana, Long Beach, Costa Mesa, and San Diego. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, West Coast Cure concentrated 45.58% of sales in Vapor Pens with year-over-year growth of 17.24% and month-over-month growth of 7.69%, while Flower held 21.53% share despite a -10.17% year-over-year decline and a 36.73% month-over-month surge. Pre-Roll accounted for 18.32% share with a -5.35% year-over-year change and a 12.00% month-over-month lift, and Concentrates at 13.58% saw a -8.42% year-over-year shift alongside a 5.71% month-over-month rise; the much smaller Edible segment at 1.00% share posted -18.32% year-over-year and 21.19% month-over-month. With average price down 4.13% year-over-year to $19.66 and Vapor Pens ranked 12 in California, the mix indicates a pivot toward volume-led recovery in core inhalables, while non-core categories are stabilizing mostly through short-term month-over-month gains rather than sustained year-over-year expansion.
The shift concentrates competitive footing in mid-priced inhalables: Vapor Pens’ 17.24% year-over-year and 7.69% month-over-month growth alongside a 12th-place rank in California positions West Coast Cure to trade share on price elasticity as average prices eased 4.13%, whereas Flower’s -10.17% year-over-year against a 36.73% month-over-month rebound signals episodic promotional spikes rather than durable share capture. Pre-Roll at -5.35% year-over-year but +12.00% month-over-month, and Concentrates at -8.42% year-over-year with +5.71% month-over-month, point to reliance on tactical lifts; this implies that maintaining or improving the 45.58% Vapor Pen mix while converting the Flower month-over-month surge into repeatable demand is the practical path to offsetting a -31.10% 24‑month sales contraction.
Competitive Landscape
West Coast Cure is currently ranked #12 in CA Vapor Pens in October 2026, a 3-place improvement from #15 year over year, but a 1-place slip from #13 three months ago; its historical peak was #11 in October 2024, placing today’s #12 just one rank below that high. Competitively, STIIIZY held at #1 while recording a -9.4% year-over-year sales change, and Jetty Extracts climbed from #4 to #3 with a 45.8% year-over-year sales increase, indicating that upward mobility is occurring above West Coast Cure’s position; meanwhile, Jeeter advanced from #9 to #5 alongside a 61.1% year-over-year lift, widening the gap that a #12 brand must close. The pattern—up 3 ranks year over year yet still 1 rank below its three-month position—implies West Coast Cure’s trajectory is positive but not compounding, and without acceleration it risks being outpaced by faster-rising competitors concentrated within the top 5.
Notable Products
West Coast Cure leans on a wide catalog with light item-level concentration: 370 products sold but the top 10 account for only 13.1% of October 2026 sales, with CUREpen - Skywalker OG Distillate Cartridge (1g) at 2.3%. That spread means revenue is dispersed across many SKUs, so most of its sales come from breadth rather than a few blockbusters.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
